Chemists’ strike: CDSCO moves to prevent shortages

The CDSCO has advised state drug controllers to prevent drug scarcity during the AIOCD's proposed e-pharmacy strike on May 20. Measures include ensuring pharmacies remain open, coordinating with police, and negotiating to keep some shops operational to avoid medicine deserts. The government emphasizes uninterrupted public access to medicines as a top priority.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uMGf1Jj
via IFTTT

Read More

NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedings

The NCLAT has ruled in favor of Lyka Labs. It overturned a previous NCLT decision. Modi Lifecare Industries must now pay Rs 63 lakh within 30 days. Failure to pay will lead to insolvency proceedings against the company. The tribunal found that Modi Lifecare acknowledged its debt. This ruling stems from unpaid royalties under a technical guidance agreement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xt5aeV0
via IFTTT

Read More

Hearzap to acquire Amplifon India, expand network to 420 hearing care centres

Hearzap is acquiring Amplifon India in a deal that will significantly expand the company's presence across the country. The combined entity will operate approximately 420 hearing care centers. With this move, Hearzap is seeking to strengthen position in the organised hearing care market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/XzVcGMp
via IFTTT

Read More

Rising input costs, export slump take a toll on drug companies' health

India's drug makers are facing a double blow. A weaker rupee makes imported raw materials more expensive. Global economic worries are also slowing down demand for Indian medicines abroad. This is squeezing profits for manufacturers. Companies are trying to focus on more profitable products. The situation presents a tough operating environment for the industry.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/UQdLPIH
via IFTTT

Read More

AbbVie loses patent plea for Hep C drug

The Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to affordable treatment for millions. The patent office refused the application after AbbVie failed to contest oppositions and chose to abandon it. This refusal prevents AbbVie from extending its patent monopoly by five years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NztJA5p
via IFTTT

Read More

Pharmacy associations to skip strike, major medicine disruption unlikely

A planned nationwide pharmacy strike on May 20 is unlikely to occur. Many retail pharmacy associations have withdrawn support. This follows assurances from the Central Drugs Standard Control Organisation that concerns about e-pharmacies are under review. Public interest and patient welfare are cited as reasons for declining the strike. Medicine availability is expected to remain uninterrupted.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/pHjOo03
via IFTTT

Read More

Athena opens northeast India’s largest integrated psychiatric hospital in Guwahati

Athena Behavioral Health opens Northeast India's largest private psychiatric hospital in Guwahati. This marks their fifth hospital nationwide. The facility offers integrated treatment for mental health and substance use disorders. It aims to address the region's growing needs and shortage of structured care. The launch signifies a crucial step in making quality mental healthcare accessible in underserved areas.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wKiVf3e
via IFTTT

Read More